PET/CT in non-Hodgkin lymphoma: an update

L Zanoni, D Bezzi, C Nanni, A Paccagnella… - Seminars in Nuclear …, 2023 - Elsevier
Non-Hodgkin lymphomas represents a heterogeneous group of lymphoproliferative
disorders characterized by different clinical courses, varying from indolent to highly …

European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours

C Nanni, C Kobe, B Baeßler, C Baues… - The Lancet …, 2023 - thelancet.com
Given the paucity of high-certainty evidence, and differences in opinion on the use of
nuclear medicine for hematological malignancies, we embarked on a consensus process …

[HTML][HTML] 18F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?

D Albano, G Treglia, F Dondi, A Calabrò, A Rizzo… - Cancers, 2023 - mdpi.com
Simple Summary The prognostic stratification of patients affected by lymphomas is critical,
and many positron-emission tomography (PET) metabolic parameters such as SUV, MTV …

[HTML][HTML] An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients

MC Ferrández, SSV Golla, JJ Eertink, BM de Vries… - Scientific Reports, 2023 - nature.com
Convolutional neural networks (CNNs) may improve response prediction in diffuse large B-
cell lymphoma (DLBCL). The aim of this study was to investigate the feasibility of a CNN …

Integration of PET in DLBCL

KL Lewis, J Trotman - Seminars in Hematology, 2023 - Elsevier
F-fluorodeoxyglucose positron emission tomography-computerized tomography (18 FDG-
PET/CT) is the gold-standard imaging modality for staging and response assessment for …

Domain-adapted large language models for classifying nuclear medicine reports

Z Huemann, C Lee, J Hu, SY Cho… - Radiology: Artificial …, 2023 - pubs.rsna.org
Purpose To evaluate the impact of domain adaptation on the performance of language
models in predicting five-point Deauville scores on the basis of clinical fluorine 18 …

Advances in positron emission tomography and radiomics

SF Barrington - Hematological Oncology, 2023 - Wiley Online Library
Positron emission tomography is established for staging and response evaluation in
lymphoma using visual evaluation and semi‐quantitative analysis. Radiomic analysis …

Baseline [18F]FDG PET features are associated with survival and toxicity in patients treated with CAR T cells for large B cell lymphoma

E Marchal, X Palard-Novello, F Lhomme… - European Journal of …, 2024 - Springer
Purpose Chimeric antigen receptor (CAR) T cells have established themselves as an
effective treatment for refractory or relapsed large B cell lymphoma (LBCL). Recently, the …

[HTML][HTML] Extracting value from total-body PET/CT image data-the emerging role of artificial intelligence

LK Shiyam Sundar, S Gutschmayer… - Cancer …, 2024 - cancerimagingjournal.biomedcentral …
The evolution of Positron Emission Tomography (PET), culminating in the Total-Body PET
(TB-PET) system, represents a paradigm shift in medical imaging. This paper explores the …

[HTML][HTML] Sensitivity of an AI method for [18F]FDG PET/CT outcome prediction of diffuse large B-cell lymphoma patients to image reconstruction protocols

MC Ferrández, SSV Golla, JJ Eertink, BM de Vries… - EJNMMI research, 2023 - Springer
Abstract Background Convolutional neural networks (CNNs), applied to baseline [18F]-FDG
PET/CT maximum intensity projections (MIPs), show potential for treatment outcome …